Pfizer’s Q2 2025 Earnings Reveal Key Growth Drivers and Market Opportunities: What Investors Need to Know
Pfizer’s Latest Earnings Beat: What Investors Need to Know Beyond the Headlines Pfizer just delivered a second-quarter performance that not only surpassed Wall Street’s expectations but also raised its full-year adjusted profit guidance. While the headline numbers are impressive—adjusted EPS of 78 cents versus the anticipated 58 cents and revenues climbing 10% year-over-year to $14.65…